NUCLEIC ACID BIOMARKER AND USE THEREOF

The present invention is directed to methods of identifying and treating a human subject harboring a tumor or other disease comprising assessing HRG gene expression at an mRNA level in the human subject and administering a treatment comprising an anti-HER3 antibody to the human subject whose HRG gen...

Full description

Saved in:
Bibliographic Details
Main Authors FREEMAN Daniel J, BECKMAN Robert Allen, JIN Xiaoping, BLUM Sabine, MENDELL-HARARY Renee Jeanne, SCHNEIDER Matthias
Format Patent
LanguageEnglish
Published 15.06.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention is directed to methods of identifying and treating a human subject harboring a tumor or other disease comprising assessing HRG gene expression at an mRNA level in the human subject and administering a treatment comprising an anti-HER3 antibody to the human subject whose HRG gene expression at an mRNA level is assessed as high. The present invention is also directed to methods of identifying a human subject harboring a tumor or other disease comprising assessing HRG gene expression at an mRNA level in the human subject and withholding a treatment comprising an anti-HER3 antibody to the human subject whose HRG gene expression at an mRNA level is assessed as low.
Bibliography:Application Number: US201615297775